This topic contains a solution. Click here to go to the answer

Author Question: For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in ... (Read 125 times)

elizabeth18

  • Hero Member
  • *****
  • Posts: 559
For a within-subjects study comparing two treatments, A and B, a researcher expects that practice in the first treatment will improve the participants' scores in the second treatment. If the order of treatments is counterbalanced, then the practice will ____.
 
  a. influence scores in treatment A, but not in treatment B
 b. influence scores in treatment B, but not in treatment A
 c. influence scores in treatment A for half the participants and scores in treatment B for half the participants
  d. not influence the scores in either treatment condition because the treatments are counterbalanced

Question 2

A yes-no question represents a(n) ____ response.
 
  a. interval response
  b. nominal
  c. multiple response
  d. ratio



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

matt

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

c

Answer to Question 2

a





 

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

The National Institutes of Health have supported research into acupuncture. This has shown that acupuncture significantly reduced pain associated with osteoarthritis of the knee, when used as a complement to conventional therapies.

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Today, nearly 8 out of 10 pregnant women living with HIV (about 1.1 million), receive antiretrovirals.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library